
    
      This is an open-label pilot feasibility telemedicine study. This pilot will involve a total
      of 37 stimulations sessions / at home visits (30- minute sessions of multichannel excitatory
      tDCS targeting the left DPFC) and the maintenance of a daily treatment diary to be completed
      by the subjects immediately after enrollment and 12 weeks following the last study visit.
    
  